Rare Disease – Rare Cardiac, Senior Health & Science Specialist - Kansas
Pfizer · 5 Locations · Global
Sales
–
Not yet analysed
Demand65
Career growth60
Healthcare fit58
Remote potential15
5-year outlook
Likely structured as base salary plus variable sales incentive; senior specialty pharma commercial roles can offer solid earnings, but exact compensation depends on experience, territory performance, and company plan.
Clinical license
Not required
Applicant reach
moderate
Seniority
senior
Employment type
–
Date found
2026-10-21
Intelligence details
Why this is worth applying to
Worth considering if you want to move into pharmaceutical commercial/sales and have cardiology or rare disease exposure, but less suitable for clinicians seeking medical affairs, research, informatics, or remote non-clinical work.
Who should apply
Cardiology nurses, pharmacists, doctors, or healthcare graduates with strong rare disease/cardiology knowledge and some sales, account management, or HCP education experience; candidates comfortable with territory travel and commercial targets.
CV angle
Reframe real clinical experience into commercial language: cardiology/rare disease knowledge, HCP education, patient journey understanding, cross-functional collaboration, compliant communication, territory/account planning, and measurable engagement or education outcomes. Do not invent sales quotas or pharma experience.
Skills to highlight
- Rare disease/cardiology knowledge
- HCP engagement and education
- Territory/account planning
- Cross-functional collaboration
- Patient access and care pathway understanding
- Compliant scientific communication
- Product launch or clinical program support
Role summary
A senior field-based Pfizer commercial specialist role in rare cardiac disease for the Kansas territory, likely focused on engaging cardiologists and health system stakeholders to support product awareness and adoption.
We publish our own intelligence summary, never the full job description. Always confirm details with the employer when you apply.